A B Zimrin, T E Warkentin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies/bloodAnticoagulants/adverse effectsAnticoagulants/immunologyChelating Agents/adverse effectsEdetic Acid/adverse effectsEdetic Acid/immunologyHeparin/adverse effectsHeparin/immunologyHumansMaleMiddle AgedPlatelet Factor 4/immunologyPulmonary Embolism/bloodPulmonary Embolism/chemically inducedPulmonary Embolism/diagnosisPulmonary Embolism/drug therapyPulmonary Embolism/immunologyThrombocytopenia/bloodThrombocytopenia/chemically inducedThrombocytopenia/diagnosisThrombocytopenia/drug therapyThrombocytopenia/immunologyTreatment OutcomeYoung Adult
Substances: See more » AntibodiesAnticoagulantsChelating AgentsPlatelet Factor 4HeparinEdetic Acid
Year: 2013 PMID: 23636478 DOI: 10.1160/TH12-12-0908
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 5.249